Good Shroom Co Inc (TSE:MUSH)
:MUSH
Want to see TSE:MUSH full AI Analyst Report?
Top Page
Good Shroom Co Inc
(MUSH)
Select Model
Select Model
Rating:59Neutral
Price Target:
C$0.15
▲(8.57% Upside)
Action:Reiterated
Date:05/21/26
The score is driven mainly by improving fundamentals (strong TTM revenue rebound and a sharp turn to positive operating/free cash flow) but is held back by still-negative profitability and compressed gross margins. Technicals add modest support (price above shorter-term averages and RSI ~60), while valuation is only moderately supportive given the P/E and no dividend data.
Positive Factors
Revenue growth
A 35.5% TTM revenue rebound signals improving top-line traction and greater product/customer uptake. Over a 2–6 month horizon this supports scale economics, better capacity utilization and provides a durable base for reinvestment in growth initiatives if management sustains execution.
Negative Factors
Negative profitability
Continued operating losses and a -5.1% net margin indicate the business has not yet converted revenue gains into sustained profitability. Persistent negative margins erode retained earnings, constrain returns to shareholders and require either margin recovery or ongoing external capital to support growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth
A 35.5% TTM revenue rebound signals improving top-line traction and greater product/customer uptake. Over a 2–6 month horizon this supports scale economics, better capacity utilization and provides a durable base for reinvestment in growth initiatives if management sustains execution.
Read all positive factors
Good Shroom Co Inc (MUSH) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$6.98M
Dividend YieldN/A
Average Volume (3M)19.64K
Price to Earnings (P/E)11.3
Beta (1Y)0.98
Revenue Growth31.54%
EPS Growth20.75%
CountryCA
Employees5
SectorConsumer Defensive
Sector Strength42
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)<0.01
Shares Outstanding51,674,683
10 Day Avg. Volume26,649
30 Day Avg. Volume19,637
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)16.94
Price to Sales (P/S)1.37
P/FCF Ratio19.46
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Good Shroom Co Inc Business Overview & Revenue Model
Company Description
Mercanto Holdings Inc. engages in the development, manufacture, and sale of instant wellness beverages. It includes traditional cannabis, probiotics, and functional mushrooms. Its brands include Velada, Nordique Royale, and Teonan. The company was...
How the Company Makes Money
null...
Good Shroom Co Inc Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
58
Neutral
Cash Flow
71
Positive
| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.18M | 3.00M | 3.89M | 3.16M | 1.22M | 242.13K |
| Gross Profit | 707.81K | 621.69K | 1.23M | 665.12K | 228.64K | 61.90K |
| EBITDA | -165.10K | -390.16K | 66.24K | -427.19K | -1.56M | -3.56M |
| Net Income | -214.67K | -412.31K | 40.60K | -452.14K | -1.63M | -3.85M |
Balance Sheet | ||||||
| Total Assets | 1.89M | 1.02M | 1.48M | 1.44M | 1.64M | 2.30M |
| Cash, Cash Equivalents and Short-Term Investments | 753.77K | 394.97K | 202.37K | 378.42K | 751.55K | 1.69M |
| Total Debt | 70.88K | 0.00 | 17.53K | 74.06K | 207.78K | 258.46K |
| Total Liabilities | 1.54M | 778.53K | 899.77K | 986.48K | 881.55K | 495.21K |
| Stockholders Equity | 344.17K | 242.01K | 583.10K | 457.57K | 762.81K | 1.80M |
Cash Flow | ||||||
| Free Cash Flow | 854.09K | 210.60K | -148.04K | -355.13K | -777.78K | -1.73M |
| Operating Cash Flow | 854.09K | 210.60K | -148.04K | -355.13K | -777.78K | -1.71M |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 70.00K | 0.00 | 2.58M |
| Financing Cash Flow | -27.00K | -18.00K | -28.02K | -18.00K | -160.00K | 247.13K |
Good Shroom Co Inc Technical Analysis
Positive
0.14
Price Trends
0.14
Positive
0.14
Negative
0.12
Positive
Market Momentum
>-0.01
Negative
57.72
Neutral
76.19
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MUSH, the sentiment is Positive. The current price of 0.14 is above the 20-day moving average (MA) of 0.12, above the 50-day MA of 0.14, and above the 200-day MA of 0.12, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 57.72 is Neutral, neither overbought nor oversold. The STOCH value of 76.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:MUSH.
Good Shroom Co Inc Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | C$6.98M | 11.26 | -99.55% | ― | 31.54% | 20.75% | |
54 Neutral | C$33.69M | -2.27 | ― | ― | ― | 13.41% | |
53 Neutral | C$12.31M | 5.19 | ― | ― | -25.05% | 67.74% | |
46 Neutral | C$12.56M | -4.56 | 899.59% | ― | ― | -95.38% |
* Consumer Defensive Sector Average
TSE:MUSH
Good Shroom Co Inc
0.14
0.09
170.00%
TSE:RVV
Revive Therapeutics
0.03
0.00
0.00%
TSE:PCLO
PharmaCielo
0.08
0.02
50.00%
TSE:SPR
Sproutly Canada
0.02
0.00
0.00%
TSE:LOBE
Lobe Sciences
0.12
0.09
360.00%
Good Shroom Co Inc Corporate Events
Business Operations and StrategyFinancial DisclosuresProduct-Related Announcements
Mercanto Holdings Doubles Revenue and Expands CBD, Infused Product Lineup in Québec
Positive
Mar 25, 2026
Mercanto Holdings Inc. reported strong Q2 2026 results, with revenue more than doubling year over year to $2.08 million, gross profit rising 137%, and EBITDA and net income both turning positive. The company highlighted a clean balance sheet, noti...
Business Operations and StrategyFinancial DisclosuresProduct-Related Announcements
Mercanto’s Quebec Vape Launch Drives Revenue Surge and Return to Profit
Positive
Feb 24, 2026
Mercanto Holdings Inc. reported that its late-quarter entry into Quebec’s new vape cartridge category, with three cartridge SKUs and a branded battery, has rapidly become a key growth engine. The launch, which coincided with the December hol...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.